90 related articles for article (PubMed ID: 8916503)
1. p53 protein overexpression in relation to risk factors for breast cancer.
van der Kooy K; Rookus MA; Peterse HL; van Leeuwen FE
Am J Epidemiol; 1996 Nov; 144(10):924-33. PubMed ID: 8916503
[TBL] [Abstract][Full Text] [Related]
2. Breast cancer, serum antioxidant vitamins, and p53 protein overexpression.
Kim MK; Park YG; Gong G; Ahn SH
Nutr Cancer; 2002; 43(2):159-66. PubMed ID: 12588696
[TBL] [Abstract][Full Text] [Related]
3. Oral contraceptive use and other risk factors in relation to HER-2/neu overexpression in breast cancer among young women.
Gammon MD; Hibshoosh H; Terry MB; Bose S; Schoenberg JB; Brinton LA; Bernstein JL; Thompson WD
Cancer Epidemiol Biomarkers Prev; 1999 May; 8(5):413-9. PubMed ID: 10350436
[TBL] [Abstract][Full Text] [Related]
4. Reproductive factors in relation to breast cancer characterized by p53 protein expression (United States).
Furberg H; Millikan RC; Geradts J; Gammon MD; Dressler LG; Ambrosone CB; Newman B
Cancer Causes Control; 2003 Sep; 14(7):609-18. PubMed ID: 14575358
[TBL] [Abstract][Full Text] [Related]
5. Mutant p53 protein overexpression in women with ipsilateral breast tumor recurrence following lumpectomy and radiation therapy.
Turner BC; Gumbs AA; Carbone CJ; Carter D; Glazer PM; Haffty BG
Cancer; 2000 Mar; 88(5):1091-8. PubMed ID: 10699900
[TBL] [Abstract][Full Text] [Related]
6. Cigarette smoking and other risk factors in relation to p53 expression in breast cancer among young women.
Gammon MD; Hibshoosh H; Terry MB; Bose S; Schoenberg JB; Brinton LA; Bernstein JL; Thompson WD
Cancer Epidemiol Biomarkers Prev; 1999 Mar; 8(3):255-63. PubMed ID: 10090304
[TBL] [Abstract][Full Text] [Related]
7. Breast cancer among young U.S. women in relation to oral contraceptive use.
White E; Malone KE; Weiss NS; Daling JR
J Natl Cancer Inst; 1994 Apr; 86(7):505-14. PubMed ID: 8133534
[TBL] [Abstract][Full Text] [Related]
8. A case-case analysis of factors related to overexpression of p53 in endometrial cancer following breast cancer.
Olson SH; Finstad CL; Harlap S; Kurian L; Saigo PE; Barakat RR
Cancer Epidemiol Biomarkers Prev; 1997 Oct; 6(10):815-7. PubMed ID: 9332764
[TBL] [Abstract][Full Text] [Related]
9. FAK overexpression and p53 mutations are highly correlated in human breast cancer.
Golubovskaya VM; Conway-Dorsey K; Edmiston SN; Tse CK; Lark AA; Livasy CA; Moore D; Millikan RC; Cance WG
Int J Cancer; 2009 Oct; 125(7):1735-8. PubMed ID: 19521985
[TBL] [Abstract][Full Text] [Related]
10. Immunohistochemical detection of c-erbB-2 and p53 in benign breast disease and breast cancer risk.
Rohan TE; Hartwick W; Miller AB; Kandel RA
J Natl Cancer Inst; 1998 Sep; 90(17):1262-9. PubMed ID: 9731732
[TBL] [Abstract][Full Text] [Related]
11. Familial and nutritional risk factors for p53 overexpression in colorectal cancer.
Freedman AN; Michalek AM; Marshall JR; Mettlin CJ; Petrelli NJ; Black JD; Zhang ZF; Satchidanand S; Asirwatham JE
Cancer Epidemiol Biomarkers Prev; 1996 Apr; 5(4):285-91. PubMed ID: 8722220
[TBL] [Abstract][Full Text] [Related]
12. p53 Alterations and protein accumulation in benign breast tissue and breast cancer risk: a cohort study.
Rohan TE; Li SQ; Hartwick R; Kandel RA
Cancer Epidemiol Biomarkers Prev; 2006 Jul; 15(7):1316-23. PubMed ID: 16835330
[TBL] [Abstract][Full Text] [Related]
13. Relationship between lifetime ovulatory cycles and overexpression of mutant p53 in epithelial ovarian cancer.
Schildkraut JM; Bastos E; Berchuck A
J Natl Cancer Inst; 1997 Jul; 89(13):932-8. PubMed ID: 9214672
[TBL] [Abstract][Full Text] [Related]
14. p53 as an independent prognostic marker in lymph node-negative breast cancer patients.
Silvestrini R; Benini E; Daidone MG; Veneroni S; Boracchi P; Cappelletti V; Di Fronzo G; Veronesi U
J Natl Cancer Inst; 1993 Jun; 85(12):965-70. PubMed ID: 8496982
[TBL] [Abstract][Full Text] [Related]
15. Lactation and a reduced risk of premenopausal breast cancer.
Newcomb PA; Storer BE; Longnecker MP; Mittendorf R; Greenberg ER; Clapp RW; Burke KP; Willett WC; MacMahon B
N Engl J Med; 1994 Jan; 330(2):81-7. PubMed ID: 8259187
[TBL] [Abstract][Full Text] [Related]
16. [Significance of overexpression of p53 protein in human breast cancer].
Inada K; Toi M; Imazawa T; Hoshina S; Hayashi K; Tominaga T
Gan To Kagaku Ryoho; 1994 May; 21(6):817-21. PubMed ID: 8185339
[TBL] [Abstract][Full Text] [Related]
17. Tumor histology and stage but not p53, Her2-neu or cathepsin-D expression are independent prognostic factors in breast cancer patients.
Korkolis DP; Tsoli E; Fouskakis D; Yiotis J; Koullias GJ; Giannopoulos D; Papalambros E; Nikiteas NI; Spiliopoulou CA; Patsouris E; Asimacopoulos P; Gorgoulis VG
Anticancer Res; 2004; 24(3b):2061-8. PubMed ID: 15274401
[TBL] [Abstract][Full Text] [Related]
18. Microvessel density and p53 overexpression in young women with breast cancer: a case-control study.
Kalfon B; Fineberg S; Gu Y; Anand K; Dalal A ; Jones J; Sparano JA
Clin Breast Cancer; 2001 Apr; 2(1):67-72. PubMed ID: 11899385
[TBL] [Abstract][Full Text] [Related]
19. p53 inactivation is a rare event in familial breast tumors negative for BRCA1 and BRCA2 mutations.
Sensi E; Tancredi M; Aretini P; Cipollini G; Naccarato AG; Viacava P; Bevilacqua G; Caligo MA
Breast Cancer Res Treat; 2003 Nov; 82(1):1-9. PubMed ID: 14672397
[TBL] [Abstract][Full Text] [Related]
20. Accumulation of p53 tumor suppressor gene protein: an independent marker of prognosis in breast cancers.
Thor AD; Moore DH II; Edgerton SM; Kawasaki ES; Reihsaus E; Lynch HT; Marcus JN; Schwartz L; Chen LC; Mayall BH
J Natl Cancer Inst; 1992 Jun; 84(11):845-55. PubMed ID: 1317462
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
